Research Topic: Hematologic malignancies

Continuous debridement combined with short-term posaconazole therapy for cutaneous mucormycosis caused by Rhizopus oryzae infection secondary to acute myeloid leukemia: a case report

An 80-year-old patient with acute myeloid leukemia developed a serious fungal skin infection caused by Rhizopus oryzae on his lower leg. Doctors treated the infection by repeatedly cleaning out the infected tissue and giving him an antifungal medication called posaconazole for just one week. Despite the short treatment duration due to cost concerns, the patient’s wound gradually healed over four months through continued surgical care, showing that sometimes focused surgical treatment can be as effective as long-term medication.

Read More »

Cellular Composition of Bronchoalveolar Lavage Fluid in Patients with Hematologic Malignancies and Invasive Pulmonary Aspergillosis: Significant Associations with Peripheral Blood Cell Counts

Researchers studied lung fluid samples from cancer patients with a serious fungal lung infection called invasive pulmonary aspergillosis. They found that blood cell counts in the lungs correlated with blood cell counts overall, but surprisingly, the cell composition in lung fluid did not predict patient survival. The study highlights that doctors need better ways to assess the lung’s immune response to this serious fungal infection beyond just counting cells.

Read More »

Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia

Researchers tested a mushroom-derived supplement called AHCC against chronic lymphocytic leukemia in laboratory and animal studies. AHCC killed leukemia cells directly and also reduced supportive cells in the tumor environment. When combined with antibody therapy, AHCC significantly improved outcomes in mouse models, suggesting it could be a promising addition to current leukemia treatments.

Read More »
Scroll to Top